Clinical Trials Directory

Trials / Unknown

UnknownNCT05471440

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in Healthcare Workers. A Multicenter, Randomised, Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
431 (actual)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years – 67 Years
Healthy volunteers
Accepted

Summary

Eighty percent of the Dutch population has completed a primary COVID-19 vaccination regimen, and 60% of the population received a booster vaccination. Waning immunity, combined with the emergence of antigenically distinct SARS-CoV-2 variants, has led to the consideration of additional booster vaccinations in the Dutch population by autumn 2022. However, despite efforts of the Dutch policymakers, the public's willingness to repeatedly receive COVID-19 booster vaccinations is declining. This is mainly due to a reduced burden of disease by COVID-19, fewer hospitalizations, and fewer deaths. However, population immunity might be one of the major factors responsible for this reduced burden of disease, possibly emphasizing the need for booster vaccinations. In this proposal we will address an important question asked by policymakers: "Are booster vaccinations in autumn recommended for the healthy population?"

Conditions

Interventions

TypeNameDescription
DRUGDirect boost mRNAParticipants will be boosted with a covid-19 vaccin after priming with mRNA
DRUGDirect boost adenoParticipants will be boosted with a covid-19 vaccin after priming with adeno
DRUGPost-poned boost mRNAParticipants will be boosted with a covid-19 vaccin after priming with mRNA
DRUGPost-poned boost adenoParticipants will be boosted with a covid-19 vaccin after priming with adeno

Timeline

Start date
2022-08-20
Primary completion
2022-09-15
Completion
2023-08-30
First posted
2022-07-22
Last updated
2023-02-15

Locations

4 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05471440. Inclusion in this directory is not an endorsement.

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW (NCT05471440) · Clinical Trials Directory